|
DDX55 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.93463039927155E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.08880024388236E-10 |
| Normal-vs-Stage2 |
4.997800E-04 |
| Normal-vs-Stage3 |
1.561500E-04 |
| Normal-vs-Stage4 |
2.404200E-03 |
| Stage1-vs-Stage2 |
7.204800E-01 |
| Stage1-vs-Stage3 |
5.794600E-01 |
| Stage1-vs-Stage4 |
4.435200E-01 |
| Stage2-vs-Stage3 |
9.183400E-01 |
| Stage2-vs-Stage4 |
6.729400E-01 |
| Stage3-vs-Stage4 |
7.529000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.05735428693288E-12 |
| Normal-vs-AfricanAmerican |
1.28699999990545E-07 |
| Normal-vs-Asian |
1.990460E-02 |
| Caucasian-vs-AfricanAmerican |
3.723200E-01 |
| Caucasian-vs-Asian |
9.267900E-02 |
| AfricanAmerican-vs-Asian |
3.633700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.32567307026466E-12 |
| Normal-vs-Female |
1.31559985128149E-10 |
| Male-vs-Female |
5.867600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.50219999953627E-07 |
| Normal-vs-Extreme_Weight |
1.23959997821999E-09 |
| Normal-vs-Obese |
7.33560001631162E-09 |
| Normal-vs-Extreme_Obese |
8.786200E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.791800E-01 |
| Normal_Weight-vs-Obese |
9.427000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.323400E-01 |
| Extreme_Weight-vs-Obese |
9.275600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.698200E-01 |
| Obese-vs-Extreme_Obese |
5.782000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.6263999999564E-06 |
| Normal-vs-Age(41-60Yrs) |
2.44115838654579E-12 |
| Normal-vs-Age(61-80Yrs) |
4.69300043270948E-10 |
| Normal-vs-Age(81-100Yrs) |
5.688400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.276800E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.924700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.871520E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.051000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.355000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.432800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62925228863742E-12 |
| Normal-VS-Type2 PRCC |
2.364100E-04 |
| Normal-VS-KIRP CIMP |
2.069600E-02 |
| Normal-VS-Unclassified PRCC |
8.26160000000353E-05 |
| Type1 PRCC-VS-Type2 PRCC |
3.92700000000357E-05 |
| Type1 PRCC-VS-KIRP CIMP |
8.548000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.527200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.695700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.233900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.745000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.43829999999612E-05 |
| Normal-vs-N1 |
2.352300E-04 |
| Normal-vs-N2 |
5.196500E-04 |
| N0-vs-N1 |
9.223700E-02 |
| N0-vs-N2 |
4.819600E-01 |
| N1-vs-N2 |
7.900600E-01 |
|
|
